Abstract
Sexual dysfunction is common with serotonergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), and does not resolve in most patients. Vortioxetine, an antidepressant with a multimodal mechanism of action, has shown low rates of sexual dysfunction in previous major depressive disorder (MDD) trials. This study compared the effects of vortioxetine and escitalopram on sexual functioning in adults with well-treated MDD experiencing treatment-emergent sexual dysfunction (TESD). Participants treated with, and responding to, citalopram, paroxetine, or sertraline were randomized to switch to either vortioxetine (10/20 mg; n = 225) or escitalopram (10/20 mg; n = 222) for 8 weeks. Sexual function was assessed using the Changes in Sexual Functioning Questionnaire Short Form (CSFQ-14), and antidepressant efficacy was assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS), Clinical Global Impressions (CGI) scale, and Profile of Mood States brief form (POMS-brief). Safety and tolerability were also assessed. The primary endpoint was change from baseline in the CSFQ-14 total score after 8 weeks of treatment. The MADRS, CGI, and POMS-brief were us...Continue Reading
References
Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
May 1, 2002·International Clinical Psychopharmacology·A WadeK Bang Hedegaard
May 10, 2002·The Journal of Clinical Psychiatry·Anita H ClaytonAlan Metz
Aug 24, 2004·The International Journal of Neuropsychopharmacology·Per BechAnders Gersel Pedersen
Jun 18, 2005·The Journal of Clinical Psychiatry·Pedro L DelgadoMichael J Detke
Jan 2, 2007·The Journal of Clinical Psychiatry·Susan G KornsteinChetan Gandhi
Jan 20, 2007·Psychopharmacology·Nikolas KleinSiegfried Kasper
Jul 14, 2007·The Journal of Sexual Medicine·Anita ClaytonMadelaine Wohlreich
Mar 31, 2009·Journal of Psychopharmacology·V S L WilliamsD S Baldwin
May 29, 2009·The Journal of Sexual Medicine·Giovanni CoronaMario Maggi
Jun 29, 2010·Primary Care Companion to the Journal of Clinical Psychiatry·Chien-Han Lai
Apr 12, 2011·The Journal of Sexual Medicine·Hatta SidiNg Chong Guan
Apr 14, 2011·Journal of Medicinal Chemistry·Benny Bang-AndersenTine Bryan Stensbøl
Jan 1, 2010·Drug, Healthcare and Patient Safety·Agnes HigginsAileen M Lynch
Dec 8, 2011·Annals of Internal Medicine·Gerald GartlehnerKathleen N Lohr
Dec 24, 2011·The American Journal of Psychiatry·Kelly PosnerJ John Mann
Jan 3, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·David S BaldwinMarianne Dragheim
Apr 13, 2012·Journal of Psychopharmacology·Jean-Philippe BoulengerIoana Florea
May 23, 2012·The Journal of Sexual Medicine·Chih-Sung LiangHsuan-Chi Su
Aug 7, 2012·International Journal of Methods in Psychiatric Research·Ronald C KesslerHans-Ullrich Wittchen
Aug 21, 2012·The Journal of Clinical Psychiatry·Neven HenigsbergMichael E Thase
Sep 12, 2012·The International Journal of Neuropsychopharmacology·Rakesh JainMichael E Thase
Dec 21, 2012·Current Medical Research and Opinion·Atul R MahableshwarkarYinzhong Chen
Feb 23, 2013·Depression Research and Treatment·David S BaldwinVasilios G Masdrakis
Apr 19, 2013·Frontiers in Pharmacology·Thibault Renoir
Aug 27, 2013·Journal of Psychiatry & Neuroscience : JPN·Sakina J Rizvi, Sidney H Kennedy
Dec 18, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ursula ReichenpfaderBradley N Gaynes
Apr 2, 2014·Postgraduate Medicine·Anita H ClaytonLata Handiwala
Jul 13, 2014·Pharmacology & Therapeutics·Connie SanchezFrancesc Artigas
Aug 26, 2014·Expert Opinion on Drug Safety·Anita H ClaytonAlexandra Elizabeth Schuck
Jan 13, 2015·Psychopharmacology·Atul R MahableshwarkarMadhukar H Trivedi
Nov 18, 2015·CNS Spectrums·Paula L JacobsenAnita H Clayton
Citations
Feb 3, 2016·Current Psychiatry Reports·Anita H Clayton, Veronica Harsh
Aug 16, 2016·The Psychiatric Clinics of North America·Anita H ClaytonJennifer G Votta
May 4, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael E ThaseEduard Vieta
Mar 2, 2017·Journal of Psychopharmacology·Marrit K de Boer, Robert A Schoevers
Feb 13, 2016·Journal of Psychopharmacology·David S BaldwinElin Reines
Apr 14, 2018·Women's Health·Rosemary Basson, Thea Gilks
Jul 6, 2017·The Cochrane Database of Systematic Reviews·Markus KoestersCorrado Barbui
Jul 27, 2018·Journal of Psychopharmacology·Michael Cronquist ChristensenDavid S Baldwin
Nov 21, 2018·Expert Opinion on Drug Discovery·Xenia GondaFrank I Tarazi
Apr 24, 2019·CNS Spectrums·Paula L JacobsenAnita Clayton
Dec 4, 2019·The Pharmacogenomics Journal·Merve Demirbugen OzH Sinan Suzen
Jun 17, 2020·Andrologia·Ayodeji Folorunsho Ajayi, Roland Eghoghosoa Akhigbe
Jul 15, 2020·Human Psychopharmacology·Vera De CarloBernardo Dell'Osso
Nov 23, 2017·Depression and Anxiety·Michael R LiebowitzRita Hanover
Mar 17, 2020·The Medical Journal of Australia·Jody Rothmore
May 24, 2019·Journal of Clinical Medicine·Angel L MontejoJosé L Villegas
Mar 16, 2018·Current Psychiatry Reports·Veronica Harsh, Anita H Clayton
Oct 9, 2019·Journal of Clinical Medicine·Angel L MontejoLaura Montejo
Nov 27, 2020·Psychopharmacology·Brunella V González CautelaJames G Pfaus
Sep 6, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·María Santos-CasadoBernardo Santos-Ramos
Mar 3, 2021·Expert Opinion on Pharmacotherapy·Dorota Danielak
Jun 14, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anja DvojkovicNela Pivac
Aug 13, 2017·Revista de psiquiatrí́a y salud mental·Estela SalagreEduard Vieta